{"entity":{"type":"insider","cik":"0001569585","url":"/insider/0001569585","json_url":"/insider/0001569585.json","name":"Bell John K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2014-02-12","last":"2019-09-19","span_basis":"filed_date"},"name_variants":[{"name":"Bell John K","source":"filing","n_filings":12,"first_seen":"2014-02-12","last_seen":"2019-09-19"}],"transactions":[{"id":9206413,"accession":"0000905718-19-000779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-19-000779","line_url":"/filing/0000905718-19-000779#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.6784,"price_display":"0.68","price_state":"stated","total_value":23744.0,"total_display":"23,744.00","total_whole":"23,744","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-19","scope":"insider"},{"id":7992457,"accession":"0000905718-19-000777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-19-000777","line_url":"/filing/0000905718-19-000777#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.6784,"price_display":"0.68","price_state":"stated","total_value":23744.0,"total_display":"23,744.00","total_whole":"23,744","shares_owned_after":44701.0,"shares_owned_after_display":"44,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-16","scope":"insider"},{"id":5358998,"accession":"0001213900-17-012293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-17-012293","line_url":"/filing/0001213900-17-012293#line-2","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18129.0,"shares_display":"18,129","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":14684.49,"total_display":"14,684.49","total_whole":"14,684","shares_owned_after":95019.0,"shares_owned_after_display":"95,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-17","scope":"insider"},{"id":5358994,"accession":"0001213900-17-012293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-012293","line_url":"/filing/0001213900-17-012293#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1871.0,"shares_display":"1,871","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":1515.51,"total_display":"1,515.51","total_whole":"1,516","shares_owned_after":76890.0,"shares_owned_after_display":"76,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-15","filed_date":"2017-11-17","scope":"insider"},{"id":5040254,"accession":"0001213900-17-006880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006880","line_url":"/filing/0001213900-17-006880#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4167.0,"shares_display":"4,167","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":15001.2,"total_display":"15,001.20","total_whole":"15,001","shares_owned_after":49455.0,"shares_owned_after_display":"49,455","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-28","scope":"insider"},{"id":4326726,"accession":"0001213900-17-006217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006217","line_url":"/filing/0001213900-17-006217#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":21200.0,"total_display":"21,200.00","total_whole":"21,200","shares_owned_after":45288.0,"shares_owned_after_display":"45,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":8856857,"accession":"0001013762-15-000735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-15-000735","line_url":"/filing/0001013762-15-000735#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":137000.0,"shares_owned_after_display":"137,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-16","filed_date":"2015-07-17","scope":"insider"},{"id":6360794,"accession":"0001013762-14-001391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-001391","line_url":"/filing/0001013762-14-001391#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":7600.0,"total_display":"7,600.00","total_whole":"7,600","shares_owned_after":87000.0,"shares_owned_after_display":"87,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-24","scope":"insider"},{"id":6330902,"accession":"0001013762-14-001067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-001067","line_url":"/filing/0001013762-14-001067#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":4970.0,"total_display":"4,970.00","total_whole":"4,970","shares_owned_after":79000.0,"shares_owned_after_display":"79,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-08","filed_date":"2014-09-10","scope":"insider"},{"id":6598792,"accession":"0001013762-14-001061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-001061","line_url":"/filing/0001013762-14-001061#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":0.7796,"price_display":"0.78","price_state":"stated","total_value":6236.8,"total_display":"6,236.80","total_whole":"6,237","shares_owned_after":72000.0,"shares_owned_after_display":"72,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-04","filed_date":"2014-09-05","scope":"insider"},{"id":6217524,"accession":"0001013762-14-000444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-000444","line_url":"/filing/0001013762-14-000444#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":64000.0,"shares_owned_after_display":"64,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-22","filed_date":"2014-04-24","scope":"insider"},{"id":6724361,"accession":"0001013762-14-000264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-000264","line_url":"/filing/0001013762-14-000264#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":32500.0,"total_display":"32,500.00","total_whole":"32,500","shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-20","scope":"insider"},{"id":6516544,"accession":"0001013762-14-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-000129","line_url":"/filing/0001013762-14-000129#line-1","is_derivative":false,"issuer_cik":"0001498382","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001498382","owner_cik":"0001569585","owner_name":"Bell John K","owner_display_name":"Bell John K","owner_url":"/insider/0001569585","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":0.8338,"price_display":"0.83","price_state":"stated","total_value":7504.2,"total_display":"7,504.20","total_whole":"7,504","shares_owned_after":19000.0,"shares_owned_after_display":"19,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-11","filed_date":"2014-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001498382","name":"DelMar Pharmaceuticals, Inc.","url":"/issuer/0001498382","role":"Director","n_filings":12,"first_seen":"2014-02-12","last_seen":"2019-09-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001569585","retrieved_at":"2026-08-25T08:39:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}